Farallon Capital Management’s Repros Therapeutics Inc. RPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2015
Q2 | – | Sell |
-200,000
| Closed | -$1.72M | – | 119 |
|
2015
Q1 | $1.72M | Sell |
200,000
-100,000
| -33% | -$859K | 0.03% | 85 |
|
2014
Q4 | $2.99M | Sell |
300,000
-400,000
| -57% | -$3.99M | 0.04% | 74 |
|
2014
Q3 | $6.93M | Hold |
700,000
| – | – | 0.11% | 69 |
|
2014
Q2 | $12.1M | Hold |
700,000
| – | – | 0.17% | 59 |
|
2014
Q1 | $12.4M | Hold |
700,000
| – | – | 0.24% | 55 |
|
2013
Q4 | $12.8M | Buy |
700,000
+230,000
| +49% | +$4.21M | 0.27% | 53 |
|
2013
Q3 | $12.6M | Buy |
470,000
+42,000
| +10% | +$1.13M | 0.26% | 51 |
|
2013
Q2 | $7.9M | Buy |
+428,000
| New | +$7.9M | 0.15% | 57 |
|